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Abstract - This study aimed to provide the first comprehensive report into the local pattern of mycobacterial isolation. We 
used the GenoType MTBC and CM/AS assays (Hain Lifescience) to perform speciation of 1 096 mycobacterial cultures 
isolated from respiratory specimens, one culture per patient, in Serbia over a 12-month period. The only species of the 
Mycobacterium tuberculosis complex (MTBC) identified in our study was M. tuberculosis, with an isolation rate of 88.8%. 
Ten different species of nontuberculous mycobacteria (NTM) were recognized, and the five most frequently isolated spe-
cies were, in descending order, M. xenopi, M. peregrinum, M. gordonae, M. avium and M. chelonae. In total, NTM isolates 
accounted for 11.2% of all isolates of mycobacteria identified in pulmonary specimens. Our results suggest that routine 
differentiation among members of the MTBC is not necessary, while routine speciation of NTM is required. 
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INTRODUCTION
Currently,  the  genus  Mycobacterium  encompasses 
163 species and 13 subspecies described in the list of 
bacterial species with approved names (www.bacte-
rio.cict.fr/m/mycobacterium.html). Strict pathogens 
are members of the M. tuberculosis complex (MTBC) 
and M. leprae, while all other species are collectively 
referred to as nontuberculous mycobacteria (NTM), 
and  are  considered  opportunistic  pathogens.  The 
mycobacteria grouped in the MTBC are highly clon-
al, but differ significantly in terms of their host trop-
isms, phenotypic characteristics and pathogenicity. 
The complex includes obligate human pathogens M. 
tuberculosis, M. africanum and M. canettii, while spe-
cies adapted to animals are M. bovis (cattle), M. caprae 
(sheep and goats), M. microti (rodents) and M. pinni-
pedii (seals and sea lions) (Gagneux and Small, 2007; 
Wirth et al., 2008). Novel MTBC pathogens such as 
M. mungi in banded mongooses (Alexander et al., 
2010), and M. orygis in animals of the Bovidae family 
(van Ingen et al., 2012) have recently been described. 
Although all members of the complex are considered 
tubercle bacilli, the most important causative agent 
of tuberculosis (TB) in humans and the most fre-
quently isolated species from clinical specimens is M. 
tuberculosis. With almost 9 million new TB cases and 
1.4 million TB deaths in 2011, TB remains one of the 
major global health problems (WHO, 2012). NTM, 
though not as important as the MTBC, are being in-
creasingly recognized as etiological agents of human 
diseases (Griffith et al., 2007; Kendall and Winthrop, 
2013). Human disease resulting from NTM infection 
is classified into four major clinical syndromes: pul-
monary disease, lymphadenitis, skin and soft tissue 
infections  and  disseminated  disease.  The  isolation 
of NTM from clinical specimens increases in many 
countries,  but  the  differences  in  geographical  dis-554 IRENA ŽIVANOVIĆ ET AL.
tribution of the species encountered are significant 
(Martin-Casabona et al., 2004; Griffith et al., 2007; 
Kendall and Winthrop, 2013). 
The accurate identification of mycobacteria and, 
in particular, discrimination of MTBC isolates from 
NTM are essential for the appropriate treatment of 
patients, and have obvious epidemiological implica-
tions. Identification of mycobacteria to the species 
level based on the cultural and biochemical charac-
teristics is often difficult and, in some instances, not 
possible (Springer et al., 1996). In addition, it is time 
consuming  and  error  prone.  The  introduction  of 
highly sensitive and specific molecular methods for 
the rapid identification of mycobacteria has changed 
the algorithm of laboratory diagnostics of mycobac-
teria and considerably increased the rapidity and ac-
curacy of the process. Various techniques are used, 
such as DNA sequencing, PCR and real-time PCR 
assays, and reverse hybridization-based line probe 
assays  (Harmsen  et  al.,  2003;  Richter  et  al.,  2006; 
Pérez-Osorio et al., 2011). The main targets within 
the genome of mycobacteria are 16S rRNA, the hsp65 
gene, the internal transcribed spacer (ITS) and the 
rpoB  gene  (Harmsen  et  al.,  2003;  Pérez-Osorio  et 
al., 2011). Commercially available tests for the mo-
lecular identification of mycobacteria, such as the 
GenoType assays (Hain Lifescience GmbH, Nehren, 
Germany), are of particular importance to routine 
laboratory practice. The GenoType assays are line 
probe assays based on reverse hybridization of mul-
tiplex PCR DNA amplicons with probes for different 
mycobacterial species immobilized to a nitrocellu-
lose strip. The GenoType MTBC test identifies mem-
bers of the MTBC based on detection of 23S rRNA 
gene sequences specific for members of the complex, 
species-specific sequences of the gyrB gene and the 
Region of Difference 1 (RD1). The GenoType CM as-
say (CM, common mycobacteria) targets 23S rRNA, 
and enables identification of the MTBC and the most 
frequently isolated NTM, while the GenoType AS 
assay (AS, additional species) also targets 23S rRNA 
and identifies uncommonly isolated NTM (Richter 
et al., 2003; Richter et al., 2006). The three tests were 
introduced into the TB laboratory network in Serbia 
in 2009.
The incidence rate of TB has significantly de-
clined in the population in Serbia from 37 per 100 
000 individuals in 2003, to 18 per 100 000 individuals 
in 2011. Thus, an increase in the prevalence of NTM 
isolation and disease may be expected, as was noted 
in  other  countries  (Martin-Casabona  et  al.,  2004; 
Griffith et al., 2007; Kendall and Winthrop, 2013). 
However, laboratory diagnostics of mycobacteria in 
Serbia is still primarily focused on M. tuberculosis. 
Prior to the introduction of molecular tests into the 
TB laboratory network in Serbia, the differentiation 
of MTBC species was not performed, apart from dif-
ferentiation between M. tuberculosis and M. bovis. As 
far as NTM are concerned, identification of the most 
common NTM species was achievable only in four 
large laboratories, i.e. the majority of NTM isolates 
in the country were recognized as Mycobacterium 
sp. only. In this study, we used the GenoType MTBC 
and CM/AS assays to identify all mycobacterial cul-
tures isolated from respiratory specimens, one cul-
ture per patient, in Serbia over a 12-month period, 
and provide the first comprehensive insight into the 
local pattern of mycobacterial isolation.
MATERIALS AND METHODS
Cultures analyzed
The number of patients with pulmonary specimens 
yielding a positive mycobacterial culture in Serbia 
over a 12-month period (December 1, 2010 through 
November 30, 2011) was 1 131. For the purposes of 
this study, one culture per patient was sent to the Na-
tional Reference Laboratory for identification. The 
isolates of mycobacteria originated from 28 labora-
tories from all regions of the country. All cultures 
were grown on Löwenstein-Jensen (LJ) medium and 
identified  as  mycobacteria  based  on  their  pheno-
typic characteristics, i.e. microscopical and cultural 
characteristics. All strains were tested by the Geno-
Type MTBC assay, and the isolates not recognized as 
MTBC were further tested by CM and AS assays. 
GenoType assays
DNA  isolation,  PCR,  hybridization  and  detection SPECIATION OF MyCOBACTERIA IN SERBIA 555
were performed according to the manufacturer’s in-
structions. The test results were interpreted using a 
template sheet and interpretation charts. The MTBC 
strip contains 13 probes: 1 – conjugate control which 
documents the efficiency of conjugate binding and 
substrate reaction; 2 – universal control which tar-
gets the 23S rRNA gene and detects Gram-positive 
bacteria with a high guanine (G) + cytosine (C) con-
tent; 3 – probe specific for the MTBC which targets 
23S rRNA; 4-12 – species specific probes (gyrB gene); 
Table 1. Identification of mycobacteria by the GenoType MTBC assay (interpretation chart).
Mycobacterium species Band pattern
M. tuberculosis/“M. canettii“ 1,2,3,4,5,6,7,8
M. africanum 1,2,3,4,5,6,7,10
M. microti 1,2,3,4,5,6,10,11
M. bovis ssp. bovis 1,2,3,4,7,9,10
BCG 1,2,3,4,7,9,10,13
M. bovis ssp. caprae 1,2,3,5,7,10,12
M. bovis ssp. caprae1 1,2,3,4,5,7,10
1 Approximately 5% of the subspecies M. bovis caprae exhibit a banding pattern according to the right column.
Table 2. Identification of mycobacteria by the GenoType CM assay (interpretation chart).
Mycobacterium species Band pattern
High GC Gram positive bacterium 1,2,(10)
Mycobacterium sp.1 1,2,3,(10)
M. avium ssp. 1,2,3,4
M. chelonae/M. immunogenum 1,2,3,5,10
M. abscessus/M. immunogenum 1,2,3,5,6,10
M. fortuitum 12 1,2,3,7,14
M. fortuitum 22/M. mageritense 1,2,3,7
M. gordonae 1,2,3,8,10
M. intracellulare 1,2,3,9
M. scrofulaceum3 1,2,3,9,10
M. interjectum 1,2,3,9,10,11
M. kansasii 1,2,3,(9),10,12
M. malmoense4/M. haemophilum/M. palustre 1,2,3,(9),10,13
M. marinum/M. ulcerans5 1,2,3,10,15
M. tuberculosis complex6 1,2,3,10,16
M. peregrinum/M. alvei/M. septicum 1,2,3,14
M. xenopi 1,2,3,17
1 Species may possibly be further differentiated with the GenoType Mycobacterium AS kit.
2 Due to variations in the probe region M. fortuitum is divided into two groups.
3 M. “paraffinicum” and M. parascrofulaceum show the same banding pattern as M. scrofulaceum.
4M. nebraskense shows the same banding pattern. M. haemophilum can be identified by the GenoType Mycobacterium AS kit.
5 M. ulcerans can be identified by the GenoType Mycobacterium AS kit.
6 For further differentiation use GenoType MTBC kit.556 IRENA ŽIVANOVIĆ ET AL.
and 13 – probe for M. bovis BCG (RD1). The MTBC 
species identified by the assay are listed in Table 1. 
The CM and AS strips contain 17 probes: 1 – conju-
gate control; 2 – universal control; 3 – genus control; 
and 4-17 – species specific probes. With the Geno-
Type CM assay, 15 patterns can be obtained from 23 
species (Table 2), while with the AS assay 16 patterns 
can be obtained from 18 species (Table 3).
RESULTS
Out of 1 131 cultures of mycobacteria recovered from 
pulmonary specimens, one culture per patient, over 
a 12-month period in Serbia, 35 were contaminated 
and therefore excluded from the study. In total, 1 
096 cultures were tested by the GenoType assays and 
summarized results are shown in Chart 1. All 1 096 
cultures were tested by using the GenoType MTBC 
assay. Membership of the MTBC was confirmed in 
971 isolates, and all the isolates were identified as M. 
tuberculosis species. No other species of MTBC was 
detected in the sample analyzed. The remaining 125 
isolates were tested by the CM assay and 123 were 
identified as NTM. Identification to the species level 
was achieved in 86 isolates; 37 cultures were identi-
fied as Mycobacterium sp., while for two strains iden-
tification as mycobacterial species failed. These two 
isolates were recognized as Gram-positive bacteria 
with a high G+C content in their DNA. Further iden-
tification of the 37 strains identified as Mycobacte-
rium sp. by the CM test was performed using the AS 
assay, but none of them was identified to the species 
Table 3. Identification of mycobacteria by the GenoType AS assay (interpretation chart).
Mycobacterium species Band pattern
High GC Gram positive bacterium 1,2,(12)
Mycobacterium spec. 1,2,3,(12)
M. simiae 1,2,3,4,6
M. mucogenicum 1,2,3,5,12
M. goodii 1,2,3,6,7,14
M. celatum I+III 1,2,3,6,12,14
M. smegmatis 1,2,3,6,14
M. genavense/M. triplex 1,2,3,6,16,17
M. lentiflavum 1,2,3,6,16
M. heckeshornense 1,2,3,7,10
M. szulgai2/M. intermedium 1,2,3,8,12
M. phlei 1,2,3,8,16
M. haemophilum1 1,2,3,9,12
M. kansasii3
1,2,3,9,10,12
1,2,3,9,10,12,13
1,2,3,10,12
1,2,3,10,12,13
M. ulcerans 1,2,3,11,12
M. gastri 1,2,3,12,13
M. asiaticum 1,2,3,12,15
M. shimoidei 1,2,3,12,16
1 M. nebraskense shows the same banding pattern as M. haemophilum.
2 If this banding pattern is generated with the GenoType Mycobacterium AS kit, a differentiation of M. szulgai and M. intermedium can 
be performed using the GenoType Mycobacterium CM test. M. szulgai will display the banding pattern 1, 2, 3, 10 and 11; M. interme-
dium will display the pattern 1, 2, 3, 10.
3 Due to sequence variations, 4 different M. kansasii banding patterns are possible.SPECIATION OF MyCOBACTERIA IN SERBIA 557
level. All 37 isolates were recognized as Mycobacte-
rium sp. by the AS test as well. Two strains that were 
not recognized as mycobacterial species by the CM 
assay were also tested by the AS assay, and identi-
fi  cation as Gram-positive bacteria with a high G+C 
content was confi  rmed. In summary, out of 1 094 
Chart 1. Th   e identifi  cation of 1096 mycobacterial cultures by the GenoType MTBC, CM and AS assays.
Chart 2. Frequency of NTM species among 86 isolates identifi  ed to the species level.558 IRENA ŽIVANOVIĆ ET AL.
cultures definitely identified as mycobacteria, 88.8% 
were identified as M. tuberculosis, while the fraction 
of cultures identified as NTM was 11.2%. The most 
frequently isolated NTM species was M. xenopi (32; 
2.9%), while the isolation rates of the remaining 9 
species were as follows: M. peregrinum (11; 1%), M. 
gordonae (10; 0.9%), M. avium (7; 0.6%), M. chelonae 
(7; 0.6%), M. intracellulare (6; 0.5%), M. fortuitum (4; 
0.4%); M. kansasii (4; 0.4%); M. abscessus (3; 0.3%), 
and M. scrofulaceum (2; 0.2%). The fractions of dif-
ferentiated  NTM  species  out  of  the  total  number 
of NTM cultures identified to the species level are 
shown in Chart 2. 
DISCUSSION
In this study, we used commercially available line 
probe assays to determine the species identities of 
clinical isolates of mycobacteria in Serbia. The sam-
ple of cultures analyzed was representative, since it 
included  97%  of  all  mycobacterial  cultures  recov-
ered  from  respiratory  specimens,  one  culture  per 
patient, over the study period in the country. Our 
study showed that the most predominant mycobac-
terial species in Serbia is M. tuberculosis. This was an 
expected result, since M. tuberculosis is, by far, the 
most frequently isolated mycobacterial species from 
respiratory  specimens  worldwide.  We  performed 
the first large-scale identification to the species level 
of local MTBC strains, and M. tuberculosis was the 
only MTBC species recognized among the isolates 
tested. Lack of occurrence of other members of the 
MTBC among local MTBC strains was also a some-
what expected result. M. africanum causes up to half 
of human TB in West Africa, and has infrequently 
been isolated in some European countries, such as 
Germany, England, France and Spain. The presence 
of M. africanum in areas outside the West African 
region was mostly detected in specimens from im-
migrants from this region (de Jong et al., 2010). In 
Serbia, however, the number of immigrants, includ-
ing immigrants from Africa, is rather insignificant. 
Although M. tuberculosis and M. canettii produce 
identical patterns in the MTBC assay, and therefore 
cannot be differentiated by the test, it seems reason-
able to assume that M. canettii is not present among 
local MTBC isolates. It is an infrequently isolated 
MTBC species, mostly from patients from, or with 
connection to Africa (Brosch et al., 2002). M. microti 
is also a rarely isolated MTBC species from human 
clinical specimens, and it typically causes TB in pa-
tients with immunologic deficits (Xavier et al., 2007). 
M. bovis used to be an important pathogen in Serbia 
decades ago, but the control programs focused on 
bovine TB, primarily pasteurization of milk and milk 
products, have significantly reduced the prevalence 
of the disease. Although a globally dispersed clonal 
complex of M. bovis, the European 1 complex, has 
recently been described (Smith et al., 2011), no M. 
bovis isolates were recognized among MTBC strains 
tested in the present study. It is noteworthy, however, 
that a case of lymph node TB caused by M. bovis was 
registered in here two years ago (unpublished data). 
M. caprae has been recognized as a causative agent of 
human TB contracted from animals in different parts 
of Europe, and it is typically present in rural regions 
(Prodinger et al., 2002). Since Serbia is a largely rural 
country, we were particularly interested in the pos-
sible presence of this MTBC species among local iso-
lates of mycobacteria, but none were detected among 
the strains tested. The MTBC assay does not enable 
identification of M. pinnipedii, M. mungi and M. ory-
gis, the three most recently recognized members of 
the MTBC. Nevertheless, we do not believe that this 
is a limitation of our study, since M. pinnipedii and 
M. orygis are exceptionally rarely isolated from hu-
mans (Kiers et al., 2008; van Ingen et al., 2012), while 
transmission of M. mungi to humans has not been 
documented so far (Alexander et al., 2010). 
As far as the pattern of isolation of NTM was con-
cerned, out of 123 NTM isolates, 86 were identified 
to the species level. Our study showed that M. xenopi 
is the most frequently identified NTM in pulmonary 
specimens from Serbia. In several recent studies re-
garding isolation rates of NTM in the Netherlands 
(van Ingen et al., 2008), Poland (Safianowska et al., 
2010)  and  Great  Britain  (Moore  et  al.,  2010),  M. 
xenopi has also been reported as one of the most fre-
quently isolated NTM from respiratory specimens. 
The high isolation rate of M. gordonae noted among 
the NTM strains tested in the present study is not SPECIATION OF MyCOBACTERIA IN SERBIA 559
surprising, since this species is typically encountered 
as a contaminant in respiratory specimens (Griffith 
et al., 2007). On the other hand, the high isolation 
rate of M. peregrinum was an unexpected result. A 
small number of cases of sporadic infections caused 
by M. peregrinum have been described (Brown-El-
liot and Wallace, 2002), but frequent occurrence of 
this rapidly growing mycobacterium in respiratory 
specimens is unusual (Martin-Casabona et al., 2004; 
Griffith et al., 2007). One possible explanation is the 
presence  of  specific  environmental  sources  of  M. 
peregrinum, e.g. water distribution systems, but the 
environmental distribution of NTM has not been in-
vestigated in Serbia so far. Isolation rates of the M. 
avium complex (MAC), which includes M. avium 
and M. intracellulare, and M. kansasii established in 
our study were significantly lower than those report-
ed in other studies (Martin-Casabona et al., 2004; 
Griffith et al., 2007; Kendall and Winthrop, 2013). 
The low frequency of MAC isolation, in particular, is 
a noteworthy finding, since it is the most frequently 
identified NTM in respiratory specimens from differ-
ent parts of the world (Martin-Casabona et al., 2004; 
Griffith et al., 2007; van Ingen et al., 2008; Moore et 
al., 2010; Simons et al., 2011; Kendall and Winthrop, 
2013). There is no apparent explanation for this find-
ing, but it has already been perceived that the isola-
tion of NTM species is constantly changing in most 
of the geographical areas studied (Martin-Casabona 
et al., 2004). It should be noted that in 37 NTM cul-
tures, 30% of the 123 NTM isolates recognized in 
the present study were identified as Mycobacterium 
sp. only. Although determination of the clinical rel-
evance of NTM isolates from pulmonary specimens 
was beyond the scope of this study, we retrospec-
tively analyzed the laboratory records in order to 
establish the possible clinical significance of these 
isolates. We used the microbiological component of 
the American Thoracic Society (ATS) criteria (Grif-
fith et al., 2007), and none of the 37 cases analyzed 
met the criteria. Namely, none of the patients had 
multiple (at least two) sputum specimens that yield-
ed a positive culture of mycobacteria. In addition, 16 
isolates identified as Mycobacterium sp. originated 
from the same regional laboratory, which may indi-
cate a specific environmental exposure. These results 
suggest that other molecular methods for the further 
identification of isolates recognized as Mycobacte-
rium sp. are not necessary in the routine diagnostic 
algorithm.
The  results  obtained  should  lead  to  a  rational 
application of the GenoType assays in routine lab-
oratory  diagnostics  of  mycobacterial  infections  in 
Serbia, since we intend to increase the annual frac-
tions of mycobacterial cultures identified by the mo-
lecular assays. As noted above, the GenoType tests 
were introduced into the country in 2009. Out of the 
total number of mycobacterial cultures isolated (one 
culture  per  patient  was  counted),  the  fractions  of 
cultures identified by the assays were 23% and 42% 
in 2009 and 2010, respectively. Our results suggest 
that routine differentiation among members of the 
MTBC is not necessary, while routine speciation of 
NTM, on the other hand, is required. NTM isolates 
accounted for 11.2% of all isolates of mycobacteria 
identified  in  pulmonary  specimens.  Rapid  specia-
tion that distinguishes MTBC from NTM is an im-
portant prerequisite for the proper management of 
patients with mycobacterial infections, and will be 
introduced as a required standard into routine labo-
ratory diagnostics of these infections in Serbia. The 
results of the study also indicate that assessment of 
the NTM disease burden in Serbia as well as a search 
for the environmental sources of these bacteria, are 
needed.
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